FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to infectious diseases and phthisiology. Laboratory factors are determined: hemoglobin (H) grams per liter, erythrocyte sedimentation rate mm per hour ESR (C). Indicators are assigned with quantitative values, i.e. each indicator is assigned an experimentally determined weight value in the form of a product of a constant coefficient and a quantitative value of the indicator: (-0.018154) and quantitative level of hemoglobin (H); (0.025609) and the quantitative level of ESR (C) and is summed with a constant equal to (-0.95142) with subsequent calculation by formula: probability = , where e is base of natural logarithm = 2.71828947, z is sum of numerical values of each of indicators, z=(-0,95142)+(-0,018154)x(H)+(0,025609)x(C). Derived probability is used to conclude that it is advisable to follow and treat the patient with HIV-infected tuberculosis when entering a FSIN hospital in an intensive care unit. If probability is 50% or more, the risk of a lethal outcome and the need to hospitalize the patient in the intensive care unit are predicted. If the probability is less than 50%, the patient is hospitalized in a hospital ward.
EFFECT: method enables determining a probability of a fatal outcome in a patient with HIV-infected tuberculosis when hospitalized FSIN is administered according to a limited number of laboratory parameters having high sensitivity and specificity for prediction.
1 cl, 2 ex, 2 tbl, 1 dwg
Authors
Dates
2021-02-10—Published
2020-07-20—Filed